Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A cone opsin double knockout mouse reveals long-term cone survival and provides a platform for gene therapy.

Research square·2026
Same author

Balloon-Expandable Versus Self-Expanding Valves in Patients With Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same author

Computed Tomography Sizing Algorithm for Transcatheter Aortic Valve Implantation in Bicuspid Valve: Results From the CASPER Registry.

The Canadian journal of cardiology·2026
Same author

Pre-Existing and New-Onset Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Implantation.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Novel insights on ventricular arrhythmias in cardiac amyloidosis: an updated narrative review.

Revista espanola de cardiologia (English ed.)·2026
Same author

Different Types of Aortic Valve Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement.

Structural heart : the journal of the Heart Team·2026

Related Experiment Video

Updated: May 21, 2025

Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves
07:12

Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves

Published on: August 23, 2011

15.7K

Initial experience with the Crea Aortic Valve System - a first-in-human study.

Carlos Calderas1, Maurizio Taramasso2, Jimmy Levy1

  • 1PoliclĂ­nica Metropolitana, Caracas, Venezuela.

Asiaintervention
|March 21, 2025
PubMed
Summary
This summary is machine-generated.

The new Crea Aortic Valve (CAV) system demonstrated successful implantation and performance in high-risk patients with severe aortic stenosis. Early safety data showed no major adverse events at six months, supporting further clinical evaluation.

More Related Videos

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.0K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

13.9K

Related Experiment Videos

Last Updated: May 21, 2025

Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves
07:12

Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves

Published on: August 23, 2011

15.7K
Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.0K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

13.9K

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Devices

Background:

  • Transcatheter aortic valve implantation (TAVI) offers a minimally invasive approach for severe aortic stenosis (AS).
  • The Crea Aortic Valve (CAV) is an investigational self-expanding transcatheter heart valve with promising preclinical results.

Purpose of the Study:

  • To evaluate the technical success, device performance, and early safety of the novel CAV system.
  • To assess the CAV system in a first-in-human study for patients with severe AS.

Main Methods:

  • Prospective evaluation of three high-risk AS patients undergoing TAVI with the CAV system.
  • Assessment using Valve Academic Research Consortium (VARC)-3 criteria, computed tomography angiography, and serial transthoracic echocardiography (TTE).
  • Monitoring of hemodynamic parameters and paravalvular leak (PVL) at baseline, post-procedure, and at 1- and 6-month follow-ups.

Main Results:

  • Successful CAV implantation was achieved in all three patients, with good device usability and positioning.
  • Hemodynamic improvements included reduced Vmax (<2 m/s) and mean gradient (<10 mmHg), with trivial PVL.
  • One patient required a permanent pacemaker for atrioventricular block; no strokes, heart failure, or renal failure occurred by 6 months.

Conclusions:

  • The CAV system met its primary endpoints for technical success and performance according to VARC-3 criteria.
  • The device demonstrated favorable early safety and efficacy in this initial human study.
  • Larger clinical trials are warranted to further establish the CAV system's efficacy and safety profile.